A Senzer medical device for delivering pharmaceutical-grade cannabinoids has been granted ISO certification for Design and Development. According to the respiratory inhaler company, the certification may be the first of its kind for this type of device.
Authorizing body SGS certified that under the ISO criteria, Senzer is approved for the ‘Design Development of medical device respiratory inhalers for the delivery of pharmaceutical cannabinoids.’ According to Senzer, this is the first such approval within the pharmaceutical cannabinoid space. Officials with the company said it underlined the unique nature of its offering, for which more than 300 patents have been granted worldwide.
Senzer has developed a technology platform based around its breath-activated inhaler, which takes a different approach from all other respiratory presentations. With this platform, cannabinoids are delivered without heat or combustion, and in a defined dose, providing users with certainty that they are ingesting the correct amount and form of